School of Medicine
Showing 121-140 of 631 Results
-
Albert Park, MD
Clinical Assistant Professor, Medicine
BioAlbert Park, MD, is a Clinical Assistant Professor and academic hospitalist in the Division of Hospital Medicine at Stanford University School of Medicine. He earned his MD from Harvard Medical School and completed his internal medicine residency at Stanford, where he subsequently served as Chief Resident.
His academic interests span clinical outcomes research and medical education. He approaches research through retrospective and observational methods, with interests that include infectious disease and critical care. As an educator, he is drawn to bedside teaching and clinical reasoning, and has worked with medical students and residents across inpatient settings throughout his training. Clinically, he is dedicated to ensuring that patients and families feel informed and supported throughout their hospitalization, with a particular commitment to translating the complexity of acute illness into clear, accessible language. -
David J. Park, MD, PhD, FCNS
Clinical Assistant Professor, Neurosurgery
Current Research and Scholarly InterestsThe goal of our Laboratory is to improve patients’ care and outcomes by analyzing clinical data from thousands of patients treated at our institution. Our current primary areas of interest are benign tumors, brain and spine metastases, and neurogenetic disorders.
Our lab is led by Dr. Steven D. Chang and Dr. David J. Park and proudly hosts talented young clinical scientists from around the world.
Link: https://med.stanford.edu/neurosurgery/research/NeuroOncLab.html -
Jon Park, MD, FRCSC
Saunders Family Professor
Current Research and Scholarly InterestsNon-fusion dynamic spinal stabilization, artificial disc technologies, and regenerative spinal technologies.
-
Jun Hyung Park
Research and Development Science and Engineer 1, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordI joined in Stanford Cyclotron and Radiochemistry Facility in 2014. I focus on routine radiopharmaceutical production, development, optimization for clinical use and supporting various of pre-clinical studies.
18F tracers; 18F-Flumazenil, 18F-FTC-146, 18F-FLT, 18F MISO, 18F AraG, 18F-FSPG etc.
11C tracers; 11C UCB-J, 11C-raclopride, 11C-PIB, 11C-methionine, 11C DPA-713, 11C MGX10, 11, 11C-CN radiochemistry platform development
15O tracers; 15O-H2O, 15O gas Inhalation study
68Ga tracers; 68Ga-DOTATATE, 68Ga-PSMA
Quality Controls; HPLC, GC, TCD GC etc. -
Junyoung Park
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Jun Young graduated from the Department of Biostatistics at the School of Public Health, Seoul National University, Korea. His major field of study is biostatistics, with a specific focus on the application of machine learning and statistical analysis to medical imaging and genetic data. During his doctoral studies, he concentrated on two primary research areas. Firstly, he dedicated himself to the development of deep learning models for medical images, primarily centered on T1-MRI and cognitive function test images related to Alzheimer's Disease. Secondly, he engaged in extensive genome-wide association analyses of medical images associated with Alzheimer's Disease, using statistical algorithms to uncover novel insights into the genetic factors contributing to this complex condition. Currently, as a postdoctoral fellow at the Greicius Lab at Stanford, he aims to develop statistical methods to discover novel structural variants and model polygenetic risk scores using long-read sequencing data.
-
KT Park MD MS
Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology
BioPrior to joining Genentech in 2018, Dr. Park was Associate Professor at Stanford University School of Medicine, Co-Director of the IBD Center at Stanford Children’s Health, and an expert in Crohn’s disease and ulcerative colitis. Currently, he is the Global Head of Gastroenterology, Hepatology & Metabolism in Product Development at Genentech and Roche. Trained as a health economist, during his tenure in academia, Dr Park held research grants and funding support focused on the cost-effectiveness of biologic treatment strategies and novel non-invasive biomarkers for children and adults with IBD. He led national research registries at the Crohn’s & Colitis Foundation and scientific/clinical committees in numerous GI societies and physicians’ organizations. He received his BA in chemistry/biochemistry at Duke University, MD at University of Tennessee, and MSc in Health Economics/Policy at Stanford where he completed his clinical and postdoctoral trainings. He is Adjunct Professor of Medicine in the Division of Gastroenterology & Hepatology at Stanford University. At Genentech Roche, Dr. Park directs a team of clinical scientists and medical directors overseeing clinical phase drug development in gastroenterology, hepatology, and metabolism.
